Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

i-Sens

Develops and manufactures self monitoring blood glucose test systems, including POCT diagnostic devices such as blood... read more Featured Products: More products

Download Mobile App





i-SENS Highlights Connected Diagnostic Systems at MEDICA 2025

By LabMedica International staff writers
Posted on 17 Nov 2025

i-SENS is presenting its latest in vitro diagnostic innovations at MEDICA 2025, highlighting connected testing platforms for clinical and near-patient applications. More...

In Hall 3, Booth B51, i-SENS is showcasing its i‑SmartCare 10 and i‑Smart 30 Pro systems alongside additional point‑of‑care (POC) analyzers intended to provide precise, efficient testing across hospital laboratories and near‑patient workflows. 

The i-SmartCare 10 is a blood gas, electrolyte, and metabolites analyzer optimized for POC use. The compact and lightweight analyzer features a high-capacity battery that supports two hours of mobile, continuous testing, plus an easy-to-manage all-in-one cartridge system. The i-Smart 30 Pro is an electrolyte analyzer that measures Na+, K+, and CI- concentrations, reporting results in 35 seconds on a color screen. Added benefits include an all-in-one cartridge that can be used for four weeks, battery power for two hours, and fast and error-free data entry using a barcode scanner.

The company will also feature the CareSens Air Continuous Glucose Monitoring System (CGMS). CareSens Air CGM is a 15-day, all-in-one sensor that provides real-time glucose monitoring, with data easily accessible through the CareSens app. The sensor is just 5 mm thick and weighs only 4.5 g.. Also on display at the i-SENS booth is a wide variety of CareSens Blood Glucose Monitoring System (BGMS) models, designed for accuracy, ease of use, and reliability in diverse care environments.

i-SENS’s participation at MEDICA 2025 underscores the company’s commitment to advancing smart, connected diagnostics that enhance clinical decision-making and improve patient outcomes. By continuously developing innovative and accessible solutions, i-SENS strives to support healthcare professionals and contribute to a more connected, data-driven future of care.

Related Links:
i-SENS


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.